Search Results - "Duret, Helene"

Refine Results
  1. 1

    Pivotal Role of Innate and Adaptive Immunity in Anthracycline Chemotherapy of Established Tumors by MATTAROLLO, Stephen R, LOI, Sherene, DURET, Helene, MA, Yuting, ZITVOGEL, Laurence, SMYTH, Mark J

    Published in Cancer research (Chicago, Ill.) (15-07-2011)
    “…We show, in a series of established experimental breast adenocarcinomas and fibrosarcomas induced by carcinogen de novo in mice, that the therapeutic efficacy…”
    Get full text
    Journal Article
  2. 2

    Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy by Stagg, John, Loi, Sherene, Divisekera, Upulie, Ngiow, Shin Foong, Duret, Helene, Yagita, Hideo, Teng, Michele W, Smyth, Mark J

    “…Trastuzumab, a monoclonal antibody targeting human epidermal growth factor receptor-2 (HER2/ErbB-2), has become the mainstay of treatment for HER2-positive…”
    Get full text
    Journal Article
  3. 3

    CD73-Deficient Mice Have Increased Antitumor Immunity and Are Resistant to Experimental Metastasis by STAGG, John, DIVISEKERA, Upulie, DURET, Helene, SPARWASSER, Tim, TENG, Michele W. L, DARCY, Phillip K, SMYTH, Mark J

    Published in Cancer research (Chicago, Ill.) (15-04-2011)
    “…CD73 is a cell-surface enzyme that suppresses immune responses by producing extracellular adenosine. In this study, we employed CD73 gene-targeted mice to…”
    Get full text
    Journal Article
  4. 4

    NLRP3 Suppresses NK Cell―Mediated Responses to Carcinogen-Induced Tumors and Metastases by CHOW, Melvyn T, SCENEAY, Jaclyn, PAGET, Christophe, WONG, Christina S. F, DURET, Helene, TSCHOPP, Jurg, MÖLLER, Andreas, SMYTH, Mark J

    Published in Cancer research (Chicago, Ill.) (15-11-2012)
    “…The NLRP3 inflammasome acts as a danger signal sensor that triggers and coordinates the inflammatory response upon infectious insults or tissue injury and…”
    Get full text
    Journal Article
  5. 5

    Opposing Roles for IL-23 and IL-12 in Maintaining Occult Cancer in an Equilibrium State by TENG, Michele W. L, VESELY, Matthew D, DURET, Helene, MCLAUGHLIN, Nicole, TOWNE, Jennifer E, SCHREIBER, Robert D, SMYTH, Mark J

    Published in Cancer research (Chicago, Ill.) (15-08-2012)
    “…Cancer immunoediting, the process by which the immune system controls tumor growth and shapes tumor immunogenicity, consists of 3 stages: elimination,…”
    Get full text
    Journal Article
  6. 6
  7. 7

    NKT cell adjuvant-based tumor vaccine for treatment of myc oncogene-driven mouse B-cell lymphoma by Mattarollo, Stephen R., West, Alison C., Steegh, Kim, Duret, Helene, Paget, Christophe, Martin, Ben, Matthews, Geoffrey M., Shortt, Jake, Chesi, Marta, Bergsagel, P. Leif, Bots, Michael, Zuber, Johannes, Lowe, Scott W., Johnstone, Ricky W., Smyth, Mark J.

    Published in Blood (11-10-2012)
    “…Immunomodulators are effective in controlling hematologic malignancy by initiating or reactivating host antitumor immunity to otherwise poorly immunogenic and…”
    Get full text
    Journal Article
  8. 8

    Radiotherapy Increases the Permissiveness of Established Mammary Tumors to Rejection by Immunomodulatory Antibodies by VERBRUGGE, Inge, HAGEKYRIAKOU, Jim, HAYNES, Nicole M, SHARP, Leslie L, GALLI, Mara, WEST, Alison, MCLAUGHLIN, Nicole M, DURET, Hélène, YAGITA, Hideo, JOHNSTONE, Ricky W, SMYTH, Mark J

    Published in Cancer research (Chicago, Ill.) (01-07-2012)
    “…It is becoming increasingly evident that radiotherapy may benefit from coincident or subsequent immunotherapy. In this study, we examined whether the antitumor…”
    Get full text
    Journal Article
  9. 9
  10. 10
  11. 11
  12. 12

    Role of γδ T cells in α-galactosylceramide-mediated immunity by Paget, Christophe, Chow, Melvyn T, Duret, Helene, Mattarollo, Stephen R, Smyth, Mark J

    Published in The Journal of immunology (1950) (15-04-2012)
    “…Attempts to harness mouse type I NKT cells in different therapeutic settings including cancer, infection, and autoimmunity have proven fruitful using the…”
    Get full text
    Journal Article
  13. 13

    Type I NKT‐cell‐mediated TNF‐α is a positive regulator of NLRP3 inflammasome priming by Chow, Melvyn T., Duret, Helene, Andrews, Daniel M., Faveeuw, Christelle, Möller, Andreas, Smyth, Mark J., Paget, Christophe

    Published in European journal of immunology (01-07-2014)
    “…The NLRP3 inflammasome plays a crucial role in the innate immune response to pathogens and exogenous or endogenous danger signals. Its activity must be…”
    Get full text
    Journal Article
  14. 14

    Transient Foxp3+ regulatory T‐cell depletion enhances therapeutic anticancer vaccination targeting the immune‐stimulatory properties of NKT cells by Mattarollo, Stephen R, Steegh, Kim, Li, Ming, Duret, Helene, Foong Ngiow, Shin, Smyth, Mark J

    Published in Immunology and cell biology (01-01-2013)
    “…The natural killer T (NKT) cell ligand, alpha‐galactosylceramide (α‐GalCer), represents a potential adjuvant to boost immunotherapeutic vaccination strategies…”
    Get full text
    Journal Article
  15. 15

    Anti-IL-23 Monoclonal Antibody Synergizes in Combination with Targeted Therapies or IL-2 to Suppress Tumor Growth and Metastases by TENG, Michele W. L, VON SCHEIDT, Bianca, DURET, Helene, TOWNE, Jennifer E, SMYTH, Mark J

    Published in Cancer research (Chicago, Ill.) (15-03-2011)
    “…Immunosuppressive barricades erected by tumors during the evolution of immune escape represent a major obstacle to many potentially effective cancer therapies…”
    Get full text
    Journal Article
  16. 16

    Type I NKT ‐cell‐mediated TNF ‐α is a positive regulator of NLRP 3 inflammasome priming by Chow, Melvyn T., Duret, Helene, Andrews, Daniel M., Faveeuw, Christelle, Möller, Andreas, Smyth, Mark J., Paget, Christophe

    Published in European journal of immunology (01-07-2014)
    “…The NLRP 3 inflammasome plays a crucial role in the innate immune response to pathogens and exogenous or endogenous danger signals. Its activity must be…”
    Get full text
    Journal Article
  17. 17

    Type I NKT-cell-mediated TNF-[alpha] is a positive regulator of NLRP3 inflammasome priming by Chow, Melvyn T, Duret, Helene, Andrews, Daniel M, Faveeuw, Christelle, Moller, Andreas, Smyth, Mark J, Paget, Christophe

    Published in European journal of immunology (01-07-2014)
    “…The NLRP3 inflammasome plays a crucial role in the innate immune response to pathogens and exogenous or endogenous danger signals. Its activity must be…”
    Get full text
    Journal Article
  18. 18

    Role of gamma delta T Cells in alpha -Galactosylceramide-Mediated Immunity by Paget, Christophe, Chow, Melvyn T, Duret, Helene, Mattarollo, Stephen R, Smyth, Mark J

    Published in The Journal of immunology (1950) (15-04-2012)
    “…Attempts to harness mouse type I NKT cells in different therapeutic settings including cancer, infection, and autoimmunity have proven fruitful using the…”
    Get full text
    Journal Article
  19. 19

    Studying the role of the immune system on the antitumor activity of a Hedgehog inhibitor against murine osteosarcoma by Paget, Christophe, Duret, Helene, Ngiow, Shin Foong, Kansara, Maya, Thomas, David M., Smyth, Mark J.

    Published in Oncoimmunology (01-11-2012)
    “…Recent evidence demonstrates that the efficacy of conventional anticancer therapies including chemotherapy requires a functional immune system. Here, we…”
    Get full text
    Journal Article
  20. 20